A real-world analysis of patient-reported outcomes in patients with migraine by preventive treatment eligibility status in the US and Europe

Journal of Patient-Reported Outcomes

Table 2 Patient reported migraine disability individual item scores (mean [SD]) by preventive treatment eligibility status

MIDAS individual items, mean (SD)	US		EU^a			Total (US + EU)
	Preventive Eligible^b (n = 584)	Preventive Non- Eligible^c† (n = 789)	Preventive Eligible^b (n = 1942)	Preventive Non- Eligible^c† (n = 2147)	Preventive Eligible^b (n = 2526)	Preventive Non- Eligible^c† (n = 2936)
Number of days missed work or school	1.5 (2.4)	0.7 (1.5)	1.7 (4.6)	0.7 (1.5)	1.7 (4.1)	0.7 (1.5)
Number of days with reduced productivity by half or more at work or school	2.9 (7.0)	1.0 (1.9)	2.8 (5.4)	1.5 (3.0)	2.8 (5.9)	1.4 (2.7)
Number of days missed of household work	4.6 (9.5)	1.6 (4.3)	4.0 (7.1)	1.9 (3.0)	4.2 (7.8)	1.8 (3.5)
Number of days with reduced productivity by half or more in household work	4.7 (9.2)	1.5 (3.1)	4.2 (7.0)	2.3 (3.7)	4.3 (7.6)	2.0 (3.6)
Number of days missed family or social events	2.2 (3.3)	1.1 (2.2)	3.0 (4.1)	1.6 (2.5)	2.8 (3.9)	1.4 (2.4)

^†p < 0.0001 for comparisons between preventive eligible and preventive non-eligible
^aEuropean (EU) countries included: Germany, France, Spain, Italy and, the UK
^bPreventive Eligible was defined as > 4 migraine headache days per month. ^cPreventive Non-Eligible was defined as < 4 migraine headache days/month
Preventive eligibility groups derived from PRF data; MIDAS is a patient reported outcome tool included in the patient self-completion form and so individual bases are lower
Abbreviations: MIDAS Migraine-Disability Assessment Score, SD Standard deviation